These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 8933647)
21. Multi-targeted mechanisms underlying the endothelial protective effects of the diabetic-safe sweetener erythritol. Boesten DM; Berger A; de Cock P; Dong H; Hammock BD; den Hartog GJ; Bast A PLoS One; 2013; 8(6):e65741. PubMed ID: 23755276 [TBL] [Abstract][Full Text] [Related]
22. Effect of atenolol on serum beta 2-microglobulin level in hypertensive diabetic patients. Koh H; Nambu S; Ikeda M J Clin Pharmacol; 1985 Apr; 25(3):230-2. PubMed ID: 3889077 [TBL] [Abstract][Full Text] [Related]
23. "Bitter sweet": a child case of erythritol-induced anaphylaxis. Shirao K; Inoue M; Tokuda R; Nagao M; Yamaguchi M; Okahata H; Fujisawa T Allergol Int; 2013 Jun; 62(2):269-71. PubMed ID: 23612489 [No Abstract] [Full Text] [Related]
24. Usefulness of palatinose as a caloric sweetener for diabetic patients. Kawai K; Yoshikawa H; Murayama Y; Okuda Y; Yamashita K Horm Metab Res; 1989 Jun; 21(6):338-40. PubMed ID: 2673967 [No Abstract] [Full Text] [Related]
25. Effects of erythritol on endothelial function in patients with type 2 diabetes mellitus: a pilot study. Flint N; Hamburg NM; Holbrook M; Dorsey PG; LeLeiko RM; Berger A; de Cock P; Bosscher D; Vita JA Acta Diabetol; 2014; 51(3):513-6. PubMed ID: 24366423 [TBL] [Abstract][Full Text] [Related]
27. Erythritol, a non-nutritive sugar alcohol sweetener and the main component of truvia®, is a palatable ingested insecticide. Baudier KM; Kaschock-Marenda SD; Patel N; Diangelus KL; O'Donnell S; Marenda DR PLoS One; 2014; 9(6):e98949. PubMed ID: 24896294 [TBL] [Abstract][Full Text] [Related]
28. Single oral dose safety of D-allulose in dogs. Nishii N; Nomizo T; Takashima S; Matsubara T; Tokuda M; Kitagawa H J Vet Med Sci; 2016 Jul; 78(6):1079-83. PubMed ID: 26972334 [TBL] [Abstract][Full Text] [Related]
30. Serum nonesterified fatty acids are increased in nonobese Japanese type 2 diabetic patients with microalbuminuria. Taniguchi A; Fukushima M; Sakai M; Hama K; Sakaguchi K; Nezumi N; Kishimoto H; Watanabe T; Matsumoto K; Nagasaka S; Tokuyama K; Nakai Y Diabetes Care; 2001 Oct; 24(10):1847-9. PubMed ID: 11574459 [No Abstract] [Full Text] [Related]
31. Absorption and Metabolism of the Natural Sweeteners Erythritol and Xylitol in Humans: A Dose-Ranging Study. Bordier V; Teysseire F; Senner F; Schlotterbeck G; Drewe J; Beglinger C; Wölnerhanssen BK; Meyer-Gerspach AC Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077269 [TBL] [Abstract][Full Text] [Related]
32. The artificial sweetener erythritol and cardiovascular event risk. Witkowski M; Nemet I; Alamri H; Wilcox J; Gupta N; Nimer N; Haghikia A; Li XS; Wu Y; Saha PP; Demuth I; König M; Steinhagen-Thiessen E; Cajka T; Fiehn O; Landmesser U; Tang WHW; Hazen SL Nat Med; 2023 Mar; 29(3):710-718. PubMed ID: 36849732 [TBL] [Abstract][Full Text] [Related]
33. Effect of a Chronic Intake of the Natural Sweeteners Xylitol and Erythritol on Glucose Absorption in Humans with Obesity. Bordier V; Teysseire F; Schlotterbeck G; Senner F; Beglinger C; Meyer-Gerspach AC; Wölnerhanssen BK Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836205 [TBL] [Abstract][Full Text] [Related]
34. Acute and sub-chronic oral toxicity studies of erythritol in Beagle dogs. Eapen AK; de Cock P; Crincoli CM; Means C; Wismer T; Pappas C Food Chem Toxicol; 2017 Jul; 105():448-455. PubMed ID: 28478098 [TBL] [Abstract][Full Text] [Related]
35. Mammalian metabolism of erythritol: a predictive biomarker of metabolic dysfunction. Ortiz SR; Field MS Curr Opin Clin Nutr Metab Care; 2020 Sep; 23(5):296-301. PubMed ID: 32412980 [TBL] [Abstract][Full Text] [Related]
36. Erythritol: a novel noncaloric sweetener ingredient. de Cock P World Rev Nutr Diet; 1999; 85():110-6. PubMed ID: 10647341 [No Abstract] [Full Text] [Related]
37. Elevated Erythritol: A Marker of Metabolic Dysregulation or Contributor to the Pathogenesis of Cardiometabolic Disease? Mazi TA; Stanhope KL Nutrients; 2023 Sep; 15(18):. PubMed ID: 37764794 [TBL] [Abstract][Full Text] [Related]
38. The tolerance of erythritol and xylitol based on effective dose methodologies. Bonnema A; DeCock P; Eapen A; Bosscher D Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E761. PubMed ID: 27733381 [No Abstract] [Full Text] [Related]
39. Sucralose and Erythritol - Not Too Sweet. Tilg H; Adolph TE N Engl J Med; 2023 Aug; 389(9):859-861. PubMed ID: 37646685 [No Abstract] [Full Text] [Related]
40. Reply to letter to the editor: the tolerance of erythritol and xylitol based on effective dose methodologies. Wölnerhanssen BK; Meyer Gerspach AC; Beglinger C Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E762. PubMed ID: 27733382 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]